Global Oncology Clinical Trials Market Size, Share, and COVID-19 Impact Analysis, By Phase Type (Phase I, Phase II, Phase III, and Phase IV), By Study Design (Interventional Studies, Observational Studies, and Expanded Access Studies), and By Region (North America, Europe, Asia-Pacific, Latin America, Middle East, and Africa), Analysis and Forecast 2025 - 2035

Industry: Healthcare
RELEASE DATE Jul 2025
REPORT ID SI14464
PAGES 225
REPORT FORMAT PathSoft
Request Free Sample
Description Table of Contents Scope of Report Methodology
  1. Introduction
    1. Objectives of the Study
    2. Market Definition
    3. Research Scope
  2. Research Methodology and Assumptions
  3. Executive Summary
  4. Premium Insights
    1. Porter’s Five Forces Analysis
    2. Value Chain Analysis
    3. Top Investment Pockets
      1. Market Attractiveness Analysis, By Phase Type
      2. Market Attractiveness Analysis, By Study Design
      3. Market Attractiveness Analysis, By Region
    4. Industry Trends
  5. Market Dynamics
    1. Market Evaluation
    2. Drivers
      1. Rising cancer prevalence
    3. Restraints
      1.  High trial costs
    4. Opportunities
      1.  Emerging technologies,
    5. Challenges
      1. Patient recruitment hurdles
  6. Global Oncology Clinical Trials Market Analysis and Projection, By Phase Type
    1. Segment Overview
    2. Phase I
    3. Phase II
    4. Phase III
    5. Phase IV
  7. Global Oncology Clinical Trials Market Analysis and Projection, By Study Design
    1. Segment Overview
    2. Interventional Studies
    3. Observational Studies
    4. Expanded Access Studies
  8. Global Oncology Clinical Trials Market Analysis and Projection, By Regional Analysis
    1. Segment Overview
    2. North America
      1. U.S.
      2. Canada
      3. Mexico
    3. Europe
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
    4. Asia-Pacific
      1. Japan
      2. China
      3. India
    5. South America
      1. Brazil
    6. Middle East and Africa
      1. UAE
      2. South Africa
  9. Global Oncology Clinical Trials Market-Competitive Landscape
    1. Overview
    2. Market Share of Key Players in the Oncology Clinical Trials Market
      1. Global Company Market Share
      2. North America Company Market Share
      3. Europe Company Market Share
      4. APAC Company Market Share
    3. Competitive Situations and Trends
      1. Coverage Launches and Developments
      2. Partnerships, Collaborations, and Agreements
      3. Mergers & Acquisitions
      4. Expansions
  10. Company Profiles
    1. AbbVie Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    2.   Sanofi 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    3.  Pivotal 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    4.   IQVIA Inc 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    5.   Medpace 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    6.  Novotech
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    7.   Astrazeneca
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    8. Merck & Co., Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    9.  Syneos Health
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    10.  PRA Health Sciences 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    11.  Gilead Sciences, Inc
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    12.   Eli Lilly and Company
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    13.  F. Hoffmann-La Roche Ltd 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    14.  PAREXEL International Corporation
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis
    15. Others 
      1. Business Overview
      2. Company Snapshot
      3. Company Market Share Analysis
      4. Company Coverage Portfolio
      5. Recent Developments
      6. SWOT Analysis

 

List of Table

  1. Global Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  2. Global Phase I, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)
  3. Global Phase II, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)
  4. Global Phase III, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)
  5. Global Phase IV, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)
  6. Global Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  7. Global Interventional Studies, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)
  8. Global Observational Studies, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)
  9. Global Expanded Access Studies, Oncology Clinical Trials Market, By Region, 2024-2035(USD Billion)

 

  1. North America Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  2. North America Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  3. U.S.  Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  4. U.S.  Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  5. Canada Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  6. Canada Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  7. Mexico Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  8. Mexico Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  9. Europe Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  10. Europe Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  11. Germany Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  12. Germany Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  13. France Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  14. France Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  15. U.K.  Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  16. U.K.  Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  17. Italy Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  18. Italy Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  19. Spain Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  20. Spain Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  21. Asia Pacific Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  22. Asia Pacific Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  23. Japan Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  24. Japan Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  25. China Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  26. China Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  27. India Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  28. India Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  29. South America Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  30. South America Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  31. Brazil Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  32. Brazil Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  33. The Middle East and Africa Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD   Billion)
  34. The Middle East and Africa Oncology Clinical Trials Market, By Study Design, 2024-2035(USD   Billion)
  35. UAE Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  36. UAE Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)
  37. South Africa Oncology Clinical Trials Market, By Phase Type, 2024-2035(USD Billion)
  38. South Africa Oncology Clinical Trials Market, By Study Design, 2024-2035(USD Billion)

 

List of Figures 

  1. Global Oncology Clinical Trials Market Segmentation
  2. Oncology Clinical Trials Market: Research Methodology
  3. Market Size Estimation Methodology: Bottom-Up Approach
  4. Market Size Estimation Methodology: Top-down Approach
  5. Data Triangulation
  6. Porter’s Five Forces Analysis
  7. Value Chain Analysis
  8. Top investment pocket in the Oncology Clinical Trials Market
  9. Top Winning Strategies, 2024-2035
  10. Top Winning Strategies, By Development, 2024-2035(%)
  11. Top Winning Strategies, By Company, 2024-2035
  12. Moderate Bargaining power of Buyers
  13. Moderate Bargaining power of Suppliers
  14. Moderate Bargaining power of New Entrants
  15. Low threat of Substitution
  16. High Competitive Rivalry
  17. Top Player Positioning, 2024
  18. Market Share Analysis, 2024
  19. Restraint and Drivers:  Oncology Clinical Trials Market
  20. Oncology Clinical Trials Market Segmentation, By Phase Type
  21. Oncology Clinical Trials Market For Phase I, By Region, 2024-2035 ($ Billion)
  22.  Oncology Clinical Trials Market For Phase II, By Region, 2024-2035 ($ Billion)
  23. Oncology Clinical Trials Market For Phase III, By Region, 2024-2035 ($ Billion)
  24. Oncology Clinical Trials Market For Phase IV, By Region, 2024-2035 ($ Billion)
  25. Oncology Clinical Trials Market Segmentation, By Study Design
  26.  Oncology Clinical Trials Market For Interventional Studies, By Region, 2024-2035 ($ Billion)
  27.  Oncology Clinical Trials Market For Observational Studies, By Region, 2024-2035 ($ Billion)
  28. Oncology Clinical Trials Market For Expanded Access Studies, By Region, 2024-2035 ($ Billion)
  29. AbbVie Inc: Net Sales, 2024-2035 ($ Billion)
  30. AbbVie Inc: Revenue Share, By Segment, 2024 (%)
  31. AbbVie Inc: Revenue Share, By Region, 2024 (%)
  32. Sanofi: Net Sales, 2024-2035 ($ Billion)
  33. Sanofi: Revenue Share, By Segment, 2024 (%)
  34. Sanofi: Revenue Share, By Region, 2024 (%)
  35. Pivotal: Net Sales, 2024-2035 ($ Billion)
  36. Pivotal: Revenue Share, By Segment, 2024 (%)
  37. Pivotal: Revenue Share, By Region, 2024 (%)
  38. IQVIA Inc: Net Sales, 2024-2035 ($ Billion)
  39. IQVIA Inc: Revenue Share, By Segment, 2024 (%)
  40. IQVIA Inc: Revenue Share, By Region, 2024 (%)
  41. Medpace: Net Sales, 2024-2035 ($ Billion)
  42. Medpace: Revenue Share, By Segment, 2024 (%)
  43. Medpace: Revenue Share, By Region, 2024 (%)
  44. Novotech: Net Sales, 2024-2035 ($ Billion)
  45. Novotech: Revenue Share, By Segment, 2024 (%)
  46. Novotech: Revenue Share, By Region, 2024 (%)
  47. Astrazeneca: Net Sales, 2024-2035 ($ Billion)
  48. Astrazeneca: Revenue Share, By Segment, 2024 (%)
  49. Astrazeneca: Revenue Share, By Region, 2024 (%)
  50. Merck & Co., Inc: Net Sales, 2024-2035 ($ Billion)
  51. Merck & Co., Inc: Revenue Share, By Segment, 2024 (%)
  52. Merck & Co., Inc: Revenue Share, By Region, 2024 (%)
  53. Syneos Health.: Net Sales, 2024-2035 ($ Billion)
  54. Syneos Health.: Revenue Share, By Segment, 2024 (%)
  55. Syneos Health.: Revenue Share, By Region, 2024 (%)
  56. PRA Health Sciences: Net Sales, 2024-2035 ($ Billion)
  57. PRA Health Sciences: Revenue Share, By Segment, 2024 (%)
  58. PRA Health Sciences: Revenue Share, By Region, 2024 (%)
  59. Gilead Sciences, Inc: Net Sales, 2024-2035 ($ Billion)
  60. Gilead Sciences, Inc: Revenue Share, By Segment, 2024 (%)
  61. Gilead Sciences, Inc: Revenue Share, By Region, 2024 (%)
  62. Eli Lilly and Company: Net Sales, 2024-2035 ($ Billion)
  63. Eli Lilly and Company: Revenue Share, By Segment, 2024 (%)
  64. Eli Lilly and Company: Revenue Share, By Region, 2024 (%)
  65. F. Hoffmann-La Roche Ltd: Net Sales, 2024-2035 ($ Billion)
  66. F. Hoffmann-La Roche Ltd: Revenue Share, By Segment, 2024 (%)
  67. F. Hoffmann-La Roche Ltd: Revenue Share, By Region, 2024 (%)
  68. PAREXEL International Corporation: Net Sales, 2024-2035 ($ Billion)
  69. PAREXEL International Corporation: Revenue Share, By Segment, 2024 (%)
  70. PAREXEL International Corporation: Revenue Share, By Region, 2024 (%)
  71. Others: Net Sales, 2024-2035 ($ Billion)
  72. Others: Revenue Share, By Segment, 2024 (%)
  73. Others: Revenue Share, By Region, 2024 (%)

Buy Now

  • Access to only 1 person; cannot be shared; cannot be printed
  • Access for 2 to 5 users only within same department of one company
  • Access to a company wide audience; includes subsidiary companies or other companies within a group of companies

Premium Report Details

Base Year:2024
Tables & Figures:119
Pages:225
Countries covered:25
Companies covered::21
Forecast CAGR: 5.23%
Request Discount

15% Free Customization

Share your Requirements

Request Customization

We Covered in Market

  • 24/7 Analyst Support
  • Worldwide Clients
  • Tailored Insights
  • Technology Evolution
  • Competitive Intelligence
  • Custom Research
  • Syndicated Market Research
  • Market Snapshot
  • Market Segmentation
  • Growth Dynamics
  • Market Opportunities
  • Regulatory Overview
  • Innovation & Sustainability

Connect with us

Need help to buy this report?

Inquiry Before Buy
We'll use cookies to improve and customize your experience if you continue to browse. Is it OK if we also use cookies to show you personalized ads?
Learn more and manage your cookies
Yes, Accept Cookies